What’s the best alternative medication if I stop ramipril?

The short version: switching from ramipril to an ARB (angiotensin receptor blocker) is the standard alternative that avoids the cough, and the evidence supports it.

The 1999 review comparing ACE inhibitors to ARBs states directly that ARBs do not affect bradykinin and have a "more favorable" cough profile [6]. The 2011 azilsartan study confirms this: in a head-to-head trial, cough occurred in 8.2% of the ramipril group and was not reported as a notable side effect in the ARB groups [4]. The ONTARGET trial, the largest comparison ever done, found cough in 4.2% of people on ramipril versus 1.1% on the ARB telmisartan [2]. That is about a 4-to-1 difference.

The mechanism is clean. ACE inhibitors cause cough by letting bradykinin and substance P build up in the airways [1, 5]. ARBs block the angiotensin receptor directly, leaving the bradykinin pathway alone [6]. No bradykinin buildup means no cough from that mechanism.

The evidence does not show that all ARBs are identical. The azilsartan trials show blood pressure lowering that matches or exceeds ramipril, with a cough rate no different from placebo [4]. The 1999 review notes that ARBs may provide "smoother 24-hour BP control" than ACE inhibitors [6]. There is also some evidence that ARBs may reduce dementia risk, with one study showing a hazard ratio of 0.76 for dementia compared to other cardiovascular drugs [3].

The evidence here is all manufacturer-funded or from industry-aligned sources. No long-term safety comparison of ARBs versus unmedicated controls exists in these records. The question is which drug to switch to, not whether to take any drug at all.

My call: an ARB, specifically telmisartan or azilsartan based on the evidence here, is the best alternative to ramipril when cough is the reason for stopping. The cough risk drops from about 4-8 in 100 to about 1 in 100. Confidence: high for the cough benefit, moderate for equal blood pressure control.